| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | benzoate | 0.3317 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.3457 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.5369 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.6399 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.7272 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.7806 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.7865 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8121 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8146 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8172 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8270 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8296 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8363 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8419 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8438 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8463 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8480 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8495 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8541 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8590 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8603 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8668 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8747 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8754 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8758 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8832 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8838 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8847 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8849 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8857 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8859 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8880 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8887 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8912 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8934 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8952 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8965 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.8983 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9049 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9050 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9050 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9053 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9069 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9079 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9096 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9113 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9140 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9142 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9143 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9163 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9194 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9204 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9231 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9241 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9270 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9339 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9383 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9397 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9405 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9421 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9448 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9458 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9508 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9515 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9517 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9526 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9542 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9557 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9606 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9612 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9630 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9645 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9667 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9705 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9737 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9755 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9771 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9776 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9786 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9809 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9814 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9816 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9832 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9832 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9844 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9846 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9870 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9887 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9899 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9945 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9985 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9988 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 0.9995 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0000 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0005 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0019 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0021 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0034 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0037 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0046 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0049 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0098 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0108 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0127 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0173 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0183 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0187 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0228 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0230 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0233 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0320 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0354 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0362 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0429 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0470 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0474 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0493 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0512 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0522 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0527 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0538 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0554 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0570 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0572 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0604 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0625 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0659 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0686 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0713 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0714 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0726 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0744 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0798 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0819 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0832 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0844 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.0947 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1003 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1010 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1029 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1052 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1058 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1078 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1095 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1118 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1139 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1142 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1169 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1220 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1226 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1275 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1380 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1464 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1482 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1599 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1613 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1632 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1662 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1662 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1749 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1770 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1831 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.1874 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2115 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2157 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2225 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2261 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2264 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2375 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2378 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2514 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2560 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2570 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2634 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.2966 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.3057 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.3142 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.3393 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.3480 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.3578 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.3737 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.3908 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.4955 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 1.7880 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | benzoate | 2.2095 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | benzoate | 2.3306 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | benzoate | 2.4096 | scaled units | Placebo | +71HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|